Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells
Authors
Keywords
-
Journal
JOURNAL OF NEUROCHEMISTRY
Volume 139, Issue 1, Pages 55-67
Publisher
Wiley
Online
2016-07-14
DOI
10.1111/jnc.13736
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson′s disease by increasing expression of BNDF
- (2016) Chenhui Ji et al. BRAIN RESEARCH
- Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model
- (2016) Yanwei Li et al. NEUROPHARMACOLOGY
- A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson’s disease by reducing chronic inflammation in the brain
- (2016) Lijun Cao et al. NEUROREPORT
- In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
- (2016) Michael Gejl et al. Frontiers in Aging Neuroscience
- ATG12–ATG3 connects basal autophagy and late endosome function
- (2015) Lyndsay Murrow et al. Autophagy
- Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix
- (2015) Emma Robinson et al. BASIC RESEARCH IN CARDIOLOGY
- Neuroprotective effects of (Val8)GLP-1-Glu-PAL in the MPTP Parkinson’s disease mouse model
- (2015) YanFang Zhang et al. BEHAVIOURAL BRAIN RESEARCH
- Neuroprotective effects of an oxyntomodulin analogue in the MPTP mouse model of Parkinson's disease
- (2015) WeiZhen Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mitochondria: A Therapeutic Target for Parkinson’s Disease?
- (2015) Yu Luo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Glucagon-like peptide 1 protects INS-1E mitochondria against palmitate-mediated beta-cell dysfunction: a proteomic study
- (2015) Federica Ciregia et al. Molecular BioSystems
- Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
- (2015) W. Liu et al. NEUROSCIENCE
- Autophagy deficiency in β cells blunts incretin-induced suppression of glucagon release from α cells
- (2015) Min Joo Kim et al. Islets
- Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease
- (2015) Iciar Aviles-Olmos et al. Journal of Parkinsons Disease
- GLP-1-related proteins attenuate the effects of mitochondrial membrane damage in pancreatic β cells
- (2014) Makiko Ogata et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The GLP-1 Analogue Liraglutide Protects Cardiomyocytes from High Glucose-induced Apoptosis by Activating the Epac-1/Akt Pathway
- (2014) X.-M. Wu et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Exendin-4 protects adipose-derived mesenchymal stem cells from apoptosis induced by hydrogen peroxide through the PI3K/Akt–Sfrp2 pathways
- (2014) Hao Zhou et al. FREE RADICAL BIOLOGY AND MEDICINE
- Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications
- (2014) Bikash Manandhar et al. JOURNAL OF MEDICINAL CHEMISTRY
- New drug treatments show neuroprotective effects in Alzheimer′s and Parkinson′s diseases
- (2014) Christian Hölscher Neural Regeneration Research
- Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
- (2014) Fares Bassil et al. PROGRESS IN NEUROBIOLOGY
- Glucagon-Like Peptide-1: Glucose Homeostasis and Beyond
- (2013) Young Min Cho et al. Annual Review of Physiology
- A novel acylated form of (d-Ala2)GIP with improved antidiabetic potential, lacking effect on body fat stores
- (2013) Christine M.A. Martin et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
- (2013) Jonathan E. Campbell et al. Cell Metabolism
- Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
- (2013) Christian Hölscher JOURNAL OF ENDOCRINOLOGY
- Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress
- (2013) Mohit K. Sharma et al. JOURNAL OF NEUROCHEMISTRY
- The role of autophagy in neurodegenerative disease
- (2013) Ralph A Nixon NATURE MEDICINE
- Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
- (2013) Paula L. McClean et al. NEUROPHARMACOLOGY
- Autophagy and apoptosis dysfunction in neurodegenerative disorders
- (2013) Saeid Ghavami et al. PROGRESS IN NEUROBIOLOGY
- Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
- (2013) B. Finan et al. Science Translational Medicine
- Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2
- (2013) J H Kim et al. Cell Death & Disease
- The Role of Autophagy in Parkinson's Disease
- (2013) M. A. Lynch-Day et al. Cold Spring Harbor Perspectives in Medicine
- Parkinson's disease, insulin resistance and novel agents of neuroprotection
- (2012) Iciar Aviles-Olmos et al. BRAIN
- Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders
- (2012) Isidro Salcedo et al. BRITISH JOURNAL OF PHARMACOLOGY
- (Val8)GLP-1-Glu-PAL: a GLP-1 Agonist That Improves Hippocampal Neurogenesis, Glucose Homeostasis, and β-Cell Function in High-Fat-Fed Mice
- (2012) Rachael Lennox et al. ChemMedChem
- Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
- (2012) Christian Hölscher CNS DRUGS
- Cellular models to investigate biochemical pathways in Parkinson’s disease
- (2012) Tiziana Alberio et al. FEBS Journal
- Unraveling oxyntomodulin, GLP1's enigmatic brother
- (2012) Alessandro Pocai JOURNAL OF ENDOCRINOLOGY
- Autophagy modulation as a potential therapeutic target for diverse diseases
- (2012) David C. Rubinsztein et al. NATURE REVIEWS DRUG DISCOVERY
- The Role of Atg Proteins in Autophagosome Formation
- (2011) Noboru Mizushima et al. Annual Review of Cell and Developmental Biology
- Parkinson's Disease: Genetics and Pathogenesis
- (2011) Joshua M. Shulman et al. Annual Review of Pathology-Mechanisms of Disease
- Selective autophagy mediated by autophagic adapter proteins
- (2011) Terje Johansen et al. Autophagy
- The Beclin 1 network regulates autophagy and apoptosis
- (2011) R Kang et al. CELL DEATH AND DIFFERENTIATION
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- Etiology and pathogenesis of Parkinson's disease
- (2011) Anthony H. Schapira et al. MOVEMENT DISORDERS
- GLP-1 Analogs Reduce Hepatocyte Steatosis and Improve Survival by Enhancing the Unfolded Protein Response and Promoting Macroautophagy
- (2011) Shvetank Sharma et al. PLoS One
- Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis
- (2010) R. Fan et al. DIABETES OBESITY & METABOLISM
- Missing pieces in the Parkinson's disease puzzle
- (2010) Jose A Obeso et al. NATURE MEDICINE
- Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease
- (2009) Sehee Kim et al. JOURNAL OF ENDOCRINOLOGY
- GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
- (2009) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The emerging role of autophagy in Parkinson's disease
- (2009) Zelda H Cheung et al. Molecular Brain
- Glucagon-like peptide 1 receptor stimulation by exendin-4 reverses key deficits in distinct rodent models of Parkinson's disease
- (2008) Alexander Harkavyi et al. Journal of Neuroinflammation
- Low dose rotenone treatment causes selective transcriptional activation of cell death related pathways in dopaminergic neurons in vivo
- (2008) B.H. Meurers et al. NEUROBIOLOGY OF DISEASE
- Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease
- (2007) Göran Bertilsson et al. JOURNAL OF NEUROSCIENCE RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started